posted on 2019-05-30, 05:00authored byLaurie Snyder, Megan Neely, Anne Hellkamp, Emily OâBrien, Joao Andrade, Craig Conoscenti, Thomas Leonard, Shaun Bender, Mridu Gulati, Daniel Culver, Robert Kaner, Scott Palmer, Hyun Kim
Supplemental tables. (DOCX 63 kb)
Funding
The IPF-PRO Registry is funded by Boehringer Ingelheim Pharmaceuticals, Inc. and coordinated by the Duke Clinical Research Institute. The authors received no direct compensation for the development of this manuscript.